Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to α-fodrin antibodies

Rheumatology

Volumn 46, Issue 3, 2007, Pages 479-483

  Willeke, P ^a   Gaubitz, M ^a   Schotte, H ^a   Becker, H ^a   Mickholz, E ^a   Domschke, W ^a   Schluter B ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Fodrin; CD71; Disease duration; ELISPOT; HLA DR; Interferon ; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; CD14 ANTIGEN; CD71 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 6; SPECTRIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; LABORATORY TEST; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PAROTID GLAND DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SEROLOGY; SJOEGREN SYNDROME; SYMPTOM; VOLUNTEER;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARRIER PROTEINS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MONOCYTES; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 33847366656     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel270     Document Type: Article

References (31)

1. Haneji N, Nakamura T, Takio K et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997;276:604-7.
2. Ulbricht KU, Schmidt RE, Witte T. Antibodies against alpha-fodrin in Sjögren's syndrome. Autoimmun Rev 2003;2:109-13.
3. Yanagi K, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. Eur J Immunol 1998;28:3336-45.
4. Ruffatti A, Ostuni P, Grypiotis P et al. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 2004;31:504-7.
5. Sordet C, Gottenberg JE, Goetz J et al. Anti-alpha-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome. Ann Rheum Dis 2005;64:1244-5.
6. Zandbelt MM, Vogelzangs J, Van De Putte LB, Van Venrooij WJ, Van Den Hoogen FH. Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome. Arthritis Res Ther 2004;6:R33-R38.
7. Maruyama T, Saito I, Hayashi Y et al. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. Am J Pathol 2004;165:53-61.
8. Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjögren's syndrome. Am J Pathol 2005;167:1051-9.
9. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
10. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
11. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
14. Willeke P, Schotte H, Erren M et al. Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand) 2002;48:323-9.
15. Willeke P, Schluter B, Schotte H et al. Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption. Lupus 2004;13:257-62.
16. Witte T, Matthias T, Arnett FC et al. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. J Rheumatol 2000;27:2617-20.
17. Wise CM, Agudelo CA, Semble EL, Stump TE, Woodruff RD. Comparison of parotid and minor salivary gland biopsy specimens in the diagnosis of Sjögren's syndrome. Arthritis Rheum 1988;31:662-6.
18. Witte T, Matthias T, Oppermann M et al. Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: Comparison of 2 sets of classification criteria. J Rheumatol 2003;30:2157-9.
19. Perrin D, Moller K, Hanke K, Soling HD. cAMP and Ca(2+)-mediated secretion in parotid acinar cells is associated with reversible changes in the organization of the cytoskeleton. J Cell Biol 1992;116:127-34.
20. Ulbricht KU, Schmidt RE, Witte T. Antibodies against alpha-fodrin in Sjögren's syndrome. Autoimmun Rev 2003;2:109-13.
21. Kobayashi I, Kawamura N, Okano M et al. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome. J Rheumatol 2001;28:363-5.
22. Sun D, Emmert-Buck MR, Fox PC. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome. Autoimmunity 1998;28:125-37.
23. Cha S, Brayer J, Gao J et al. A dual role for interferon-gamma in the pathogenesis of Sjögren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol 2004;60:552-65.
24. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2730-41.
25. Hasegawa H, Inoue A, Kohno M et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of auto-immune sialadenitis in MRL/lpr mice. Arthritis Rheum 2006;54:1174-83.
26. Rastellini C, Braun M, Li X et al. Prolongation of pancreatic islet graft survival by blocking transferrin receptor (CD71). Transplant Proc 2001;33:518-9.
27. Takaya M, Ichikawa Y, Shimizu H, Uchiyama M, Moriuchi J, Arimori S. Expression of MHC class II antigens and other T cell activation antigens on T cells and salivary duct epithelial cells in the salivary gland of cases of Sjögren's syndrome. Tokai J Exp Clin Med 1990;15:27-33.
28. Zeher M, Paloczi K, Szegedi G. Activation antigens in patients with Sjögren's syndrome. Haematologia (Budap) 1990;23:193-7.
29. Brookes SM, Price EJ, Venables PJ, Maini RN. Interferon-gamma and epithelial cell activation in Sjogren's syndrome. Br J Rheumatol 1995;34:226-31.
30. Vey E, Zhang JH, Dayer JM. IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol 1992;149:2040-6.
31. Gottenberg JE, Busson M, Loiseau P et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003;48:2240-5.